Methylprednisolone
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Methylprednisolone is a synthetic glucocorticoid available in oral, intramuscular, intravenous, and intra-articular formulations. IV methylprednisolone (Solu-Medrol) is frequently used for acute flares of multiple sclerosis, severe asthma, transplant rejection, and other inflammatory emergencies. The oral form (Medrol) is commonly dispensed as a dose pack for short-term anti-inflammatory therapy.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Methylprednisolone is a synthetic glucocorticoid available in oral, intramuscular, intravenous, and intra-articular formulations. NutriStack rates the supporting evidence as strong. Common adult dosing is Oral: 4–48 mg daily; IV pulse: 500–1,000 mg daily for 3–5 days; intra-articular varies by joint size (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete calcium, vitamin d, potassium. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: potent anti-inflammatory and immunosuppressive activity, multiple formulations for flexible clinical use, iv pulse therapy for acute inflammatory crises. 10 sources indexed (2017–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates transcription of inflammatory genes. Inhibits phospholipase A2 (via lipocortin induction), reducing prostaglandin and leukotriene synthesis. Suppresses NF-kB-mediated transcription of pro-inflammatory cytokines. Also reduces vascular permeability, stabilizes lysosomal membranes, and decreases immune cell activation and migration.3,7
Dosing & protocol.
Oral tablets should be taken with food. IV form given as slow infusion. Intra-articular injections should not be repeated more than every 3 months in the same joint.
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Calcium
SignificantGlucocorticoids reduce intestinal calcium absorption, increase urinary calcium loss, and accelerate bone resorption.
Vitamin D
ModerateGlucocorticoids impair activation and signaling of vitamin D, reducing calcium absorption and bone support.
Potassium
ModerateSystemic corticosteroids can promote potassium loss or shifts in susceptible patients, especially at higher doses or with other hypokalemia risks; replacement should be lab-guided.
Magnesium
ModerateChronic corticosteroid use can increase urinary magnesium losses and worsen low magnesium status.
Full safety detail.
Side effects
- Hyperglycemia
- Insomnia and mood disturbances
- Fluid retention and hypertension
- GI upset and peptic ulceration
- Increased infection risk
- Osteoporosis with chronic use
- Avascular necrosis (especially with high-dose or prolonged use)
- Adrenal suppression
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
6- 1Teprotumumab versus intravenous methylprednisolone in thyroid eye disease: A systematic reviewPMIDMehmood F, Rizvi SAR, Alam S et al. · Oman journal of ophthalmology · 2024
Mehmood F, Rizvi SAR, Alam S et al.. Teprotumumab versus intravenous methylprednisolone in thyroid eye disease: A systematic review. Oman journal of ophthalmology. 2024
- 2The role of methylprednisolone in severe COVID-19 patients: a meta-analysisPMIDXu W, Zeng Y, Han H et al. · Frontiers in medicine · 2024
Xu W, Zeng Y, Han H et al.. The role of methylprednisolone in severe COVID-19 patients: a meta-analysis. Frontiers in medicine. 2024
- 3A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasonePMIDHong S, Wang H, Li S et al. · BMC infectious diseases · 2023
Hong S, Wang H, Li S et al.. A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone. BMC infectious diseases. 2023
- 4The roles of methylprednisolone treatment in patients with COVID-19: A systematic review and meta-analysisPMIDHong S, Wang H, Zhang Z et al. · Steroids · 2022
Hong S, Wang H, Zhang Z et al.. The roles of methylprednisolone treatment in patients with COVID-19: A systematic review and meta-analysis. Steroids. 2022
- 5Methylprednisolone and local anesthetic for long-term postherpetic neuralgia: a meta-analysisPMIDZhang Y, Gao YL, Zhang LH · The Journal of dermatological treatment · 2022
Zhang Y, Gao YL, Zhang LH. Methylprednisolone and local anesthetic for long-term postherpetic neuralgia: a meta-analysis. The Journal of dermatological treatment. 2022
- 6Efficacy and Safety of Methylprednisolone Sodium Succinate in Acute Spinal Cord Injury: A Systematic ReviewPMIDFehlings MG, Wilson JR, Harrop JS et al. · Global spine journal · 2017
Fehlings MG, Wilson JR, Harrop JS et al.. Efficacy and Safety of Methylprednisolone Sodium Succinate in Acute Spinal Cord Injury: A Systematic Review. Global spine journal. 2017
Reference material
4- 7Buttgereit F et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis. 2002;61(8):718-722.Source linkedPMID
- 8Rhen T, Cidlowski JA. Anti-inflammatory action of glucocorticoids, new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711-1723.Source linkedPMID
- 9Kuper G et al. Comparative effectiveness of corticosteroid injections for trigger finger: A systematic review of randomized controlled trials. J Plast Reconstr Aesthet Surg. 2026.Source linkedPMID
- 10Douglas RS, Dailey R, Subramanian PS et al.. Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison. JAMA ophthalmology. 2022Source linkedPMID
Common questions.
Quick answers about Methylprednisolone, drawn from the data on this page.
What is Methylprednisolone?
Methylprednisolone is a synthetic glucocorticoid available in oral, intramuscular, intravenous, and intra-articular formulations. IV methylprednisolone (Solu-Medrol) is frequently used for acute flares of multiple sclerosis, severe asthma, transplant rejection, and other inflammatory emergencies. The oral form (Medrol) is commonly dispensed as a dose pack for short-term anti-inflammatory therapy.
What is Methylprednisolone used for?
Commonly cited benefits of Methylprednisolone include: Potent anti-inflammatory and immunosuppressive activity; Multiple formulations for flexible clinical use; IV pulse therapy for acute inflammatory crises; Less mineralocorticoid activity than prednisone (less fluid retention); Medrol Dosepak provides convenient tapering regimen. NutriStack rates the overall evidence as strong.
What is a typical dose of Methylprednisolone?
A typical adult dose of Methylprednisolone is Oral: 4–48 mg daily; IV pulse: 500–1,000 mg daily for 3–5 days; intra-articular varies by joint size (as prescribed by your physician). The commonly recommended form is Oral tablet (Medrol), IV injection (Solu-Medrol), or IM/intra-articular injection (Depo-Medrol). These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Methylprednisolone?
Reported side effects include hyperglycemia, insomnia and mood disturbances, fluid retention and hypertension, gi upset and peptic ulceration, increased infection risk, osteoporosis with chronic use. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Methylprednisolone?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Methylprednisolone in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.